B2M-mutant tumor patients predominantly presented with peritoneal metastases, with 2 patients having exclusively peritoneal and 2 patients with peritoneal and lymph node metastases, in contrast to only one patient with a singular hepatic metastasis. This evidence concerns the gene B2M and metastasis.